Osteoarthritis Dog Therapy – Case Study
Case Study
M/A/R/C® helped an animal health client forecast the business opportunity for a novel drug therapy
The Challenge
A company specializing in state-of-the-art pharmaceuticals for animals developed an innovative treatment for dogs suffering from osteoarthritis.
Knowing that veterinarian recommendation would be key for in-market success given the high cost to pet owners, the company turned to M/A/R/C® to estimate prescribing potential among this group.
Our client turned to us to:
- Quantify the sales potential
- Identify the long-term adoption outlook
- Explore the impact of expanded drug indications
- Determine optimal price point
The Solution
A Comprehensive Approach
1
ASSESSOR® Forecasting
2
Choice-Based Conjoint
M/A/R/C®’s sales forecasting methodology, ASSESSOR, has been proven to be predictive for ground-breaking innovations. Combining ASSESSOR with Choice-Based Conjoint offered the ability to determine the volumetric impact of alternative pricing and claims.
The Result
M/A/R/C®'s comprehensive model revealed optimized launch scenarios that allowed them to achieve their goals financially, as well as number of dogs on therapy. Results also identified the most profitable veterinarian and patient targets, as well as direction for maximizing the business beyond the first year.